menu
closed
more experienced
팝업레이어 알림
임시주주총회 소집공고
당사의 임시주주총회를 아래와 같이 개최합니다.
- 일시 : 2026년 04월 28일(화) 오전 10시
- 장소 : 서울특별시 송파구 법원로11길 7, C동 713호
㈜온코젠 서울지점 회의실 (문정동, 현대지식산업센터)
* 자세한 내용은 공지 확인바랍니다.
감사합니다.
COMPANY OVERVIEW
ONCOZEN is an oncology-focused biotechnology company devoted to provide
innovative therapies to people bravely facing cancer and rare diseases.
We see new possibilities to responsibly develop and
commercialize First-in-class & Best-in-class treatments.
PLATFORM
TECHNOLOGY
A new modality that diversifies
degradable disease-causing proteins.
A technology that targets and degrades
disease-causing proteins using the body's
UPS (Ubiquitin Proteasome System)
mediated by Chaperone complexes.
Head Office
- Address194-25, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, South Korea
- E-MailOZ2020@oncozen.co.kr
R&D Center 1
- AddressMunjeong Hyundai Knowledge Industry Center, 7, Beopwon-ro 11-gil, Songpa-gu, Seoul, South Korea
- E-MailOZ2020@oncozen.co.kr
R&D Center 2
- Address#302, College of Pharmacy, Jeonbuk National University, 20 Geonji-ro, Deokjin-gu, Jeonju-si, Jeollabuk-do, South Korea
- E-MailOZ2020@oncozen.co.kr